-
Catch up on the latest MS news here!

Ed Tobias recaps his favorite MS news stories from last week, including the start of a Phase 2 clinicial trial of a potential remyelinating therapy. Read Ed’s recap here.
Which of these columns did you enjoy most? Why?
Sorry, there were no replies found.
Log in to reply.